MG
PHVS icon

Michael Gelband’s Pharvaris PHVS Stock Holding History

Michael Gelband’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$497K Buy
14,369
+899
+7% +$27.2K ﹤0.01% 1244
2026
Q1 		$381K Buy
+13,470
New +$360K ﹤0.01% 1260

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Michael Gelband's PHVS Position: Q2 2026 in Review

Michael Gelband increased its Pharvaris (PHVS) stake by 6.7% in Q2 2026, buying an estimated $27.2K and bringing the position to 14,369 shares worth $497K. The position accounts for ﹤0.01% of the portfolio, ranked #1244.

Michael Gelband first reported a position in PHVS in Q1 2026 and has held it in 2 quarters since. 124 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Michael Gelband held 14,369 shares of Pharvaris worth $497K as of Q2 2026.
  • Michael Gelband bought 899 Pharvaris shares in Q2 2026, an estimated $27.2K.
  • Pharvaris made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1244 holding.
  • Michael Gelband first reported a position in Pharvaris in Q1 2026 and has held it in 2 quarters since.
  • 124 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.